Extendicare Stock Performance
| EXETF Stock | USD 16.00 0.19 1.17% |
On a scale of 0 to 100, Extendicare holds a performance score of 22. The firm shows a Beta (market volatility) of -1.08, which means a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Extendicare are expected to decrease slowly. On the other hand, during market turmoil, Extendicare is expected to outperform it slightly. Please check Extendicare's semi variance, and the relationship between the maximum drawdown and daily balance of power , to make a quick decision on whether Extendicare's price patterns will revert.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Extendicare are ranked lower than 22 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Extendicare reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 180 M | |
| Total Cashflows From Investing Activities | -63.7 M |
Extendicare |
Extendicare Relative Risk vs. Return Landscape
If you would invest 1,078 in Extendicare on September 27, 2025 and sell it today you would earn a total of 522.00 from holding Extendicare or generate 48.42% return on investment over 90 days. Extendicare is currently producing 0.6531% returns and takes up 2.2666% volatility of returns over 90 trading days. Put another way, 20% of traded pink sheets are less volatile than Extendicare, and 87% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Extendicare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Extendicare's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Extendicare, and traders can use it to determine the average amount a Extendicare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2881
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | EXETF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Extendicare is performing at about 22% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Extendicare by adding it to a well-diversified portfolio.
Extendicare Fundamentals Growth
Extendicare Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Extendicare, and Extendicare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Extendicare Pink Sheet performance.
| Return On Equity | 0.0018 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.12 % | |||
| Current Valuation | 556.43 M | |||
| Shares Outstanding | 83.94 M | |||
| Price To Earning | 500.00 X | |||
| Price To Book | 4.28 X | |||
| Price To Sales | 0.32 X | |||
| Revenue | 1.22 B | |||
| EBITDA | 79.64 M | |||
| Cash And Equivalents | 174.61 M | |||
| Cash Per Share | 2.08 X | |||
| Total Debt | 463.27 M | |||
| Debt To Equity | 2.85 % | |||
| Book Value Per Share | 1.49 X | |||
| Cash Flow From Operations | 63.42 M | |||
| Earnings Per Share | 0.01 X | |||
| Total Asset | 900.32 M | |||
About Extendicare Performance
By analyzing Extendicare's fundamental ratios, stakeholders can gain valuable insights into Extendicare's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Extendicare has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Extendicare has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. Extendicare Inc. was founded in 1968 and is based in Markham, Canada. Extendicare operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange.Things to note about Extendicare performance evaluation
Checking the ongoing alerts about Extendicare for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Extendicare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 13.0% of the company shares are held by company insiders |
- Analyzing Extendicare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Extendicare's stock is overvalued or undervalued compared to its peers.
- Examining Extendicare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Extendicare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Extendicare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Extendicare's pink sheet. These opinions can provide insight into Extendicare's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Extendicare Pink Sheet analysis
When running Extendicare's price analysis, check to measure Extendicare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Extendicare is operating at the current time. Most of Extendicare's value examination focuses on studying past and present price action to predict the probability of Extendicare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Extendicare's price. Additionally, you may evaluate how the addition of Extendicare to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |